Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible Mutation

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

September 2, 2024

Study Completion Date

September 2, 2024

Conditions

Cystic Fibrosis

Interventions

DRUG

CFTR modulators

Introduction of CFTR modulators by pneumologists for pneumologic issues

Trial Locations (1)

Hôpital Femme Mère Enfant, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER